page hit counter .

Important Information

DISCLAIMER

It is the responsibility of each and every person interested in investing in these funds to ensure that the investment takes place in accordance with applicable laws and other regulations. Foreign law may entail that an investment cannot be made by an investor from outside Sweden. The fund company, HealthInvest Partners AB, has no responsibility whatsoever to verify whether an investment made from outside Sweden takes place in accordance with the laws of the relevant country. The material on this site is directed only at persons in Sweden.

Disputes or claims concerning the fund shall be resolved according to Swedish law and exclusively by Swedish courts of law. There is no guarantee that an investment in a fund managed by HealthInvest Partners cannot result in a loss. This applies irrespective of otherwise positive performance on the financial markets. Past performance is no guarantee of future results.

Information from the fund company shall not be considered a recommendation to invest in the funds. Every person considering purchasing units in any of the funds must make an independent assessment of such an investment and the risks associated therewith. Investments in the funds should be seen as long-term investments. The Funds’ prospectuses and other information about the Funds are avaliable online at www.healthinvest.se. You can also receive this information at no cost by calling +46 80 440 38 30 or by sending an e-mail request to info@healthinvest.se.

COMPLAINTS

If you would like to contact HealthInvest Partners regarding a complaint, please contact Johan Stern. Any complaints should be submitted to the Fund company in writing, and are always free of charge. Investors will receive a response as soon as possible. 

You may also obtain further guidance from the Swedish Consumers’ Banking & Finance Bureau and the Swedish Consumers Insurance Bureau, as well as through the local consumer advisor. There is also the possibility to adjudicate disputes legally at the Swedish National Board for Consumer Disputes or in courts of general jurisdiction. 

 HealthInvest Partners’ information regarding complaints is available upon request.

 

THE SWEDISH MONEY LAUNDERING ACT

The Swedish Money Laundering Act entered into force on 1 August 2017. The purpose of the Swedish Money Laundering Act is to prevent the financial system from being used for money laundering or financing of terrorism. The Act covers all financial companies, including fund companies, as well as companies connected to the financial sectors such as, for example, accountants, attorneys and tax advisors.

Briefly stated, the Swedish Money Laundering Act entails that the fund company must make an assessment of the risk that a transaction is being used for money laundering. The Act imposes stringent requirements that the fund company has good knowledge of its customers and their fund transactions. As a fund company, we are therefore required to determine the purpose of a transaction, the source of the money, and what it is being used for. As a fund company, we are also obliged to verify the identity of all new customers, and we can also require the presentation of identity documents even after a long-term, customer relationship.

The customer information obtained by HealthInvest Partners is treated confidentially and is covered by secrecy and the Swedish Personal Data Act. Suspected money laundering is reported to the Swedish Financial Police which is a special unit within the Swedish National Bureau of Investigation.

PERMIT

HealthInvest Partners AB conducts fund management operations and is subject to the supervision of the Swedish Financial Supervisory Authority. The operations consist of managing HealthInvest Small & MicroCap Fund. The permit for conducting the fund operations was obtained on 6 September 2006 and the permit for conducting management of alternative investment funds was obtained on 23 January 2015.

MARKETING IN OTHER EEA COUNTRIES

The fund company is authorised to market HealthInvest Small & MicroCap Fund in Denmark and Luxembourg.